申请人:KANNUR UNIVERSITY
公开号:US10851043B1
公开(公告)日:2020-12-01
Fatty acids play very important and diverse roles in living organisms, from signal transduction, energy management, maintaining of structural integrity to the normal metabolic processes. Due to its diverse presence and roles, Fatty Acid Synthase (FAS) is an attractive drug target under different pathologic contexts such as cancer, TB, obesity, microbial infection, etc. There are a number of molecules targeting Fatty Acid Synthase (FAS) in the prior art like Cerulenin, Orlistat, Pyrimidine, Triclosan, C75 etc. The present invention relates to a compound of formula I having fatty acid synthase inhibitory properties which was confirmed by an FAS inhibition assay. The present invention also relates to a process for collection, extraction, isolation, purification and characterization of the claimed compound from marine cyanobacterium, Phormidium ambiguum.
脂肪酸在生物体内发挥着非常重要和多样的作用,包括信号转导、能量管理、维持结构完整性以及正常的新陈代谢过程。由于脂肪酸合成酶(FAS)的存在和作用多种多样,在癌症、结核病、肥胖症、微生物感染等不同病理情况下,它是一个极具吸引力的药物靶点。现有技术中有许多靶向脂肪酸合成酶(FAS)的分子,如 Cerulenin、Orlistat、Pyrimidine、Triclosan、C75 等。本发明涉及一种具有脂肪酸合成酶抑制特性的式 I 化合物,该特性已通过 FAS 抑制试验得到证实。本发明还涉及一种从海洋蓝藻 Phormidium ambiguum 中收集、提取、分离、纯化和表征所述化合物的工艺。